If High Court Reverses Teva, Litigation Costs May Increase
In recent years, the U.S. Supreme Court has shown an increasing willingness to review and, more often than not, reverse, patent law decisions from the Federal Circuit. As others have observed,...To view the full article, register now.
Already a subscriber? Click here to view full article